Similarly, fisetin suppressed the protein levels of antiapoptotic Bcl-XL and BCL-2 and increased proapoptotic BAK and BIM in HCT-116 colon cancer cells (Lim & Park, 2009). This evidence concerns the gene BCL2L1 and malignant colon neoplasm.